- Legislative, regulatory, and strategic advisor to an inner city safety net (DSH) health system, including helping secure the maximum amount of Provider Relief Funds.
- Legislative and strategic advisor to a national medical device trade association, including exempting products from health care specific taxes.
- Advised on legislative and strategic matters for a leading national inpatient rehabilitation provider, including enactment of a legislative provision to roll back restrictive Medicare regulations.
- Advisor to multiple national physician organizations on Medicare reimbursement and coverage issues, as well as cancer screening and graduate medical education (GME) policies.
- Legislative and strategic advisor to a biopharmaceutical company focused on developing therapies for rare diseases.
Senior Policy Advisor,
- Phone: +1 202 239 3562
- Email: mark.rayder@alston.com
After serving as a trusted adviser to three members of Congress and managing two successful congressional campaigns, Mark provides policy and political acumen on health care, appropriations, and other matters. Clients rely on Mark to help craft and execute their government affairs strategies.
Mark Rayder is a senior policy advisor in Alston & Bird’s Washington, D.C., office. He provides policy and political expertise on a variety of health care issues and assists clients in developing and implementing their legislative and regulatory strategy.
Before joining the firm, Mark served in the public, political, corporate, and non-profit sectors. Most recently, he was vice president of public policy for the American College of Gastroenterology and was the senior manager of government affairs at a Fortune 50 Internet and telecommunications corporation.
Named a “Top Lobbyist” by The Hill newspaper every year since 2010, Mark served as an advisor to three members of Congress, including as associate staff to the House Commerce, Justice, State, and Judiciary Appropriations Subcommittee. He also managed two successful congressional campaigns.
His policy expertise includes payment and regulatory policy pertaining to physician services, acute and post-acute care providers, biopharmaceuticals, medical devices, clinical laboratory services, public health, social determinants of health, specialty health plans, allied health, veteran’s health programs, and appropriations.
Mark received a B.A. in history from The Catholic University of America in Washington, D.C.
-
Press Release April 15, 2025Alston & Bird Named a ‘Top-Performing Lobbying Firm’ in 2024 by Bloomberg GovernmentAlston & Bird has once again been named a “Top-Performing Lobbying Firm” by Bloomberg Government. Based on key revenue metrics, the tenth annual list of leading lobbyists highlights those firms that “set the standard in 2024.”Press Release April 15, 2025Alston & Bird Named a ‘Top-Performing Lobbying Firm’ in 2024 by Bloomberg GovernmentAlston & Bird has once again been named a “Top-Performing Lobbying Firm” by Bloomberg Government. Based on key revenue metrics, the tenth annual list of leading lobbyists highlights those firms that “set the standard in 2024.”
-
Advisories December 4, 2024Health Care Advisory | Potential Medicare Physician Fee Schedule Reform in the Last Weeks of the 118th CongressA flurry of bills to reform the Medicare Physician Fee Schedule (PFS) faces the lame duck Congress. Our Health Care Group investigates how those reforms could take shape and which, if any, could find their way through the legislative process.Advisories December 4, 2024Health Care Advisory | Potential Medicare Physician Fee Schedule Reform in the Last Weeks of the 118th CongressA flurry of bills to reform the Medicare Physician Fee Schedule (PFS) faces the lame duck Congress. Our Health Care Group investigates how those reforms could take shape and which, if any, could find their way through the legislative process.
-
Speaking Engagement April 25, 2024Advocating for Policies to Broaden Access to Cancer Detection and TreatmentJoin Michael Park and Mark Rayder as they present at the St. Jude Grand Rounds.Speaking Engagement April 25, 2024Advocating for Policies to Broaden Access to Cancer Detection and TreatmentJoin Michael Park and Mark Rayder as they present at the St. Jude Grand Rounds.
-
Advisories October 27, 2023Health Care Advisory: Is Medicare Physician Fee Schedule Reform on the Horizon?
The decreasing value of Medicare reimbursements for physicians has caught the attention of a group of doctors in Congress. Our Heath Care Group explains how draft legislation would stabilize the Physician Fee Schedule (PFS) before patients lose access to health care.
Advisories October 27, 2023Health Care Advisory: Is Medicare Physician Fee Schedule Reform on the Horizon?The decreasing value of Medicare reimbursements for physicians has caught the attention of a group of doctors in Congress. Our Heath Care Group explains how draft legislation would stabilize the Physician Fee Schedule (PFS) before patients lose access to health care.
-
In the News December 1, 2021The Hill | The Hill’s Top Lobbyists 2021Mark Rayder and Tim Trysla are featured among Washington, D.C.’s “Top Lobbyists” for 2021.In the News December 1, 2021The Hill | The Hill’s Top Lobbyists 2021Mark Rayder and Tim Trysla are featured among Washington, D.C.’s “Top Lobbyists” for 2021.
-
Press Release March 10, 2021Alston & Bird Expands Bipartisan Health Care Policy and Regulatory Practice in Washington, D.C.Alston & Bird has expanded its health care policy and regulatory capabilities with the addition of James “JP” Paluskiewicz, former Republican chief health counsel for the House Committee on Energy and Commerce’s Subcommittee on Health, and a strategic alliance with Neleen Rubin, a past Democratic member of the Senate Finance Committee health policy team. Both will be key senior policy additions to the firm’s Washington, D.C. office.Press Release March 10, 2021Alston & Bird Expands Bipartisan Health Care Policy and Regulatory Practice in Washington, D.C.Alston & Bird has expanded its health care policy and regulatory capabilities with the addition of James “JP” Paluskiewicz, former Republican chief health counsel for the House Committee on Energy and Commerce’s Subcommittee on Health, and a strategic alliance with Neleen Rubin, a past Democratic member of the Senate Finance Committee health policy team. Both will be key senior policy additions to the firm’s Washington, D.C. office.
-
In the News December 9, 2020The Hill | The Hill’s Top Lobbyists 2020Mark Rayder and Tim Trysla are noted among Washington, D.C.’s top lobbyists.In the News December 9, 2020The Hill | The Hill’s Top Lobbyists 2020Mark Rayder and Tim Trysla are noted among Washington, D.C.’s top lobbyists.
Education
- The Catholic University of America (B.A., 1991)